The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 868 | 20,000 | SH | SOLE | 868 | 0 | 0 | ||
89BIO INC | COM | 282559103 | 9,319 | 393,548 | SH | SOLE | 9,319 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 8,007 | 317,730 | SH | SOLE | 8,007 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 5,752 | 407,055 | SH | SOLE | 5,752 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,856 | 113,161 | SH | SOLE | 4,856 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 7,161 | 108,000 | SH | SOLE | 7,161 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 7,360 | 400,000 | SH | SOLE | 7,360 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 9,899 | 1,095,000 | SH | SOLE | 9,899 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 1,788 | 82,000 | SH | SOLE | 1,788 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 8,912 | 843,122 | SH | SOLE | 8,912 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 4,735 | 939,500 | SH | SOLE | 4,735 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 360 | 78,000 | SH | SOLE | 360 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 20,961 | 1,017,524 | SH | SOLE | 20,961 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 6,823 | 707,830 | SH | SOLE | 6,823 | 0 | 0 | ||
CLEARSIDE BIOMEDICAL INC | COM | 185063104 | 3,987 | 1,614,000 | SH | SOLE | 3,987 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 3,314 | 90,000 | SH | SOLE | 3,314 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 8,688 | 767,500 | SH | SOLE | 8,688 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 1,432 | 315,341 | SH | SOLE | 1,432 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 8,337 | 287,000 | SH | SOLE | 8,337 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 3,872 | 381,145 | SH | SOLE | 3,872 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 7,333 | 622,500 | SH | SOLE | 7,333 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 4,392 | 392,500 | SH | SOLE | 4,392 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 1,448 | 42,500 | SH | SOLE | 1,448 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 3,089 | 97,574 | SH | SOLE | 3,089 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 9,759 | 1,579,093 | SH | SOLE | 9,759 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 5,535 | 562,500 | SH | SOLE | 5,535 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 15,176 | 536,820 | SH | SOLE | 15,176 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 5,787 | 357,689 | SH | SOLE | 5,787 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 1,542 | 9,000 | SH | SOLE | 1,542 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 569 | 3,136 | SH | SOLE | 569 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 249 | 93,332 | SH | SOLE | 249 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 456 | 13,856 | SH | SOLE | 456 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 5,053 | 154,229 | SH | SOLE | 5,053 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 4,446 | 200,289 | SH | SOLE | 4,446 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 1,396 | 14,000 | SH | SOLE | 1,396 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 8,870 | 118,500 | SH | SOLE | 8,870 | 0 | 0 | ||
SEELOS THERAPEUTICS INC | COM | 81577F109 | 8,582 | 1,719,812 | SH | SOLE | 8,582 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 3,724 | 823,000 | SH | SOLE | 3,724 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 1,748 | 45,000 | SH | SOLE | 1,748 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 5,706 | 255,180 | SH | SOLE | 5,706 | 0 | 0 | ||
TRILLIUM THERAPEUTICS INC | COM NEW | 89620X506 | 7,105 | 661,565 | SH | SOLE | 7,105 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 5,665 | 2,293,388 | SH | SOLE | 5,665 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 7,604 | 394,000 | SH | SOLE | 7,604 | 0 | 0 | ||
VINCERX PHARMA INC | *W EXP 12/24/202 | 92731L114 | 2,101 | 520,000 | SH | SOLE | 2,101 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 26,190 | 12,295,767 | SH | SOLE | 26,190 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 7,384 | 412,500 | SH | SOLE | 7,384 | 0 | 0 |